Anticoagulation, novel agents, and procedures: can we pardon the interruption?
Publication
, Journal Article
Garcia, DA; Granger, CB
Published in: Circulation
July 17, 2012
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Circulation
DOI
EISSN
1524-4539
Publication Date
July 17, 2012
Volume
126
Issue
3
Start / End Page
255 / 257
Location
United States
Related Subject Headings
- beta-Alanine
- Warfarin
- Thromboembolism
- Male
- Humans
- Hemorrhage
- Female
- Dabigatran
- Cardiovascular System & Hematology
- Benzimidazoles
Citation
APA
Chicago
ICMJE
MLA
NLM
Garcia, D. A., & Granger, C. B. (2012). Anticoagulation, novel agents, and procedures: can we pardon the interruption? Circulation, 126(3), 255–257. https://doi.org/10.1161/CIRCULATIONAHA.112.115188
Garcia, David A., and Christopher B. Granger. “Anticoagulation, novel agents, and procedures: can we pardon the interruption?” Circulation 126, no. 3 (July 17, 2012): 255–57. https://doi.org/10.1161/CIRCULATIONAHA.112.115188.
Garcia DA, Granger CB. Anticoagulation, novel agents, and procedures: can we pardon the interruption? Circulation. 2012 Jul 17;126(3):255–7.
Garcia, David A., and Christopher B. Granger. “Anticoagulation, novel agents, and procedures: can we pardon the interruption?” Circulation, vol. 126, no. 3, July 2012, pp. 255–57. Pubmed, doi:10.1161/CIRCULATIONAHA.112.115188.
Garcia DA, Granger CB. Anticoagulation, novel agents, and procedures: can we pardon the interruption? Circulation. 2012 Jul 17;126(3):255–257.
Published In
Circulation
DOI
EISSN
1524-4539
Publication Date
July 17, 2012
Volume
126
Issue
3
Start / End Page
255 / 257
Location
United States
Related Subject Headings
- beta-Alanine
- Warfarin
- Thromboembolism
- Male
- Humans
- Hemorrhage
- Female
- Dabigatran
- Cardiovascular System & Hematology
- Benzimidazoles